The Role of PPAR𝛾 Receptors and Leukotriene B4 Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer
Pancreatic cancer is a devastating disease in which current therapies are inadequate. Separate lines of research have identified the 5-lipoxygenase/leukotriene B4 receptor pathway and the PPAR𝛾 pathway as potential targets for prevention or treatment of this disease. LY293111 was originally designed...
Saved in:
| Main Authors: | Thomas E. Adrian, Rene Hennig, Helmut Friess, Xianzhong Ding |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2008/827096 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPAR𝛾)
by: Saoirse E. O'Sullivan, et al.
Published: (2009-01-01) -
Introduction of Leukotriene Receptor Antagonists in Manitoba
by: C Macie, et al.
Published: (2006-01-01) -
Leukotriene Receptor Antagonists and Related Compounds
by: Sally E Wenzel
Published: (1999-01-01) -
Role of Leukotriene Receptor Antagonists in Asthma
by: Chih-Hsing Hung
Published: (2012-08-01) -
Cysteinyl-Leukotriene Receptors and Cellular Signals
by: G. Enrico Rovati, et al.
Published: (2007-01-01)